FDA inspection
Beximco Pharmaceuticals Limited: FDA inspection ending Jan 22, 2015
FDA inspection 914961 · No Action Indicated (NAI) · Gazipur
Key facts
| Inspection ID | 914961 |
|---|---|
| Firm | Beximco Pharmaceuticals Limited |
| FEI number | 3008763868 |
| Address | 1711 Tongi |
| City | Gazipur |
| Country | Bangladesh |
| Fiscal year | 2015 |
| Inspection end date | Jan 22, 2015 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data